Associate Professor Tahsin Ozatli is a senior oncologist at Istinye University Liv Hospital, specialising in complex gastrointestinal cancers and tumours of the digestive tract.

• Coordinates care for patients with Pancreatic Neuroendocrine Tumours (pNETs) within a multidisciplinary team
• Recognised as an Associate Professor for his contribution to oncological medicine
• Trained at the Ankara Oncology Clinic, one of Turkey's major specialist cancer centres
• Manages targeted therapy and chemotherapy protocols for hormonal and non-hormonal tumours

Professor Alco is a leading radiation oncologist at Medipol Acibadem District Hospital with high-level academic expertise in treating complex tumours.

• Specialises in precise radiation therapy to target neuroendocrine tumours while sparing healthy tissue
• Holds the rank of Professor at Istanbul Medipol University's Department of Radiation Oncology
• Fellow of the Department of Radiation Oncology at Demiroglu Bilim University
• Trained at Istanbul School of Medicine, one of Turkey's premier medical institutions

Associate Professor Nail Paksoy is a highly regarded medical oncologist who specialises in targeted systemic therapies for complex tumours at Medipol Bahçelievler University Hospital.

• Published research on the efficacy of Capecitabine and Temozolomide for neuroendocrine tumours
• Holds ESMO Board Certification in Medical Oncology, an international gold standard for cancer care
• Investigates peptide receptor radionuclide therapy (PRRT) – a molecular treatment that delivers radiation directly to tumour cells
• Served as a subinvestigator in international clinical trials for pancreatic and gastrointestinal cancers

Professor Muzaffer Al is a lead surgeon at Büyük Anadolu Hospital with high-level training in oncological cancer surgery from Cerrahpaşa Faculty of Medicine.

• Specialises in laparoscopic pancreatic surgery – uses small incisions for quicker recovery and less scarring
• Completed postgraduate training in metabolic and oncological surgery at Istanbul University
• Focuses on minimally invasive techniques for treating tumours of the digestive tract
• Fellow of the Turkish Surgical Association with extensive surgical volume in complex cases

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Mustafa Serkan Alemdar is a dual-qualified specialist in internal medicine and medical oncology at the Medical Park Antalya Hospital Complex.

• Specialises in medical oncology at Akdeniz University – a leading Turkish centre for complex cancer care
• Manages systemic treatments for neuroendocrine cases, including hormone-based therapies and chemotherapy
• Experienced in multidisciplinary care for pancreatic tumours at major training and research hospitals
• Treats patients at a JCI-accredited facility, ensuring high standards for international healthcare protocols

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries